Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short-term treatment effectiveness
Clin Transl Allergy
.
2023 Feb;13(2):e12223.
doi: 10.1002/clt2.12223.
Authors
Dong Liu
1
2
3
,
Jingyun Li
1
3
,
Yunbo Gao
1
,
Feifei Cao
1
,
Wei Xiong
1
,
Chengshuo Wang
1
2
3
4
,
Yuan Zhang
1
,
Luo Zhang
1
2
3
4
Affiliations
1
Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
2
Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
3
Beijing Laboratory of Allergic Diseases and Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
4
Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing, China.
PMID:
36825515
PMCID:
PMC9911623
DOI:
10.1002/clt2.12223
No abstract available
Publication types
Letter
Grants and funding
2022YFC2504100/National key R&D program of China
IRT13082/The program for the Changjiang scholars and innovative research team
2019-I2M-5-022/CAMS innovation fund for medical sciences
2022-1-1091/Capital's funds for health improvement and research
81970849/Natural Science Foundation of China
82071022/Natural Science Foundation of China
82271141/Natural Science Foundation of China
Z211100002921060/Beijing Municipal Science & Technology Commission